De Novo Molecular Design

---

Databite AI is building an intelligent drug discovery platform designed to understand disease at the molecular, cellular, and systems level.

At the core of the platform is ProteiniX AI, our protein and therapeutic intelligence engine. ProteiniX AI combines protein structure, molecular interactions, mutation analysis, drug design, biological networks, multimodal data, and predictive modeling to help accelerate the journey from disease hypothesis to therapeutic candidate.

Our goal is not simply to predict whether a molecule binds to a protein.

Our goal is to understand:

What should be targeted.
How it should be targeted.
What molecule could work.
Why it could work.
What could make it fail.
And how the disease may respond or evolve.

ProteiniX AI is designed to analyze proteins not as static structures, but as dynamic biological systems.

The platform integrates protein sequence, structure, conformational behavior, mutations, molecular interactions, biological pathways, chemical space, and disease context to generate deeper therapeutic insights.

From identifying druggable pockets to designing new molecules and predicting resistance mechanisms, ProteiniX AI is being developed as a unified computational environment for modern drug discovery.

ProteiniX AI evaluates protein surfaces and structural ensembles to identify potential therapeutic intervention points.

The platform can prioritize:

• Orthosteric binding sites
• Allosteric pockets
• Mutation-specific pockets
• Protein–protein interaction interfaces
• Previously hidden or transient binding sites

Each potential site can be evaluated based on predicted druggability, accessibility, structural stability, biological relevance, and disease association.

Instead of relying only on existing compound libraries, ProteiniX AI is being developed to generate novel molecular candidates directly against biological targets.

The system can explore chemical structures based on multiple objectives including:

• Target affinity
• Structural complementarity
• Selectivity
• Molecular stability
• Solubility
• Permeability
• Pharmacokinetic properties
• Toxicity risk
• Synthetic feasibility

This transforms drug discovery from simply searching chemical libraries into actively designing new therapeutic candidates.